CA2533400C - Preparations pharmaceutiques cannabinoides - Google Patents

Preparations pharmaceutiques cannabinoides Download PDF

Info

Publication number
CA2533400C
CA2533400C CA2533400A CA2533400A CA2533400C CA 2533400 C CA2533400 C CA 2533400C CA 2533400 A CA2533400 A CA 2533400A CA 2533400 A CA2533400 A CA 2533400A CA 2533400 C CA2533400 C CA 2533400C
Authority
CA
Canada
Prior art keywords
cannabis
thc
cannabinoids
formulation
cbd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2533400A
Other languages
English (en)
Other versions
CA2533400A1 (fr
Inventor
Brian Whittle
Geoffrey Guy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Research Ltd
Original Assignee
GW Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0103638A external-priority patent/GB0103638D0/en
Priority claimed from US09/827,158 external-priority patent/US6730330B2/en
Priority claimed from GB0111597A external-priority patent/GB2377633A/en
Priority claimed from GB0121715A external-priority patent/GB2381194A/en
Priority claimed from US09/951,022 external-priority patent/US7025992B2/en
Application filed by GW Pharma Ltd filed Critical GW Pharma Ltd
Priority claimed from CA002438097A external-priority patent/CA2438097C/fr
Publication of CA2533400A1 publication Critical patent/CA2533400A1/fr
Application granted granted Critical
Publication of CA2533400C publication Critical patent/CA2533400C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
CA2533400A 2001-02-14 2002-02-14 Preparations pharmaceutiques cannabinoides Expired - Lifetime CA2533400C (fr)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
GB0103638.3 2001-02-14
GB0103638A GB0103638D0 (en) 2001-02-14 2001-02-14 Pharmaceutical formulations
US28004401P 2001-03-30 2001-03-30
US60/280,044 2001-03-30
US09/827,158 2001-04-05
US09/827,158 US6730330B2 (en) 2001-02-14 2001-04-05 Pharmaceutical formulations
GB0111597.1 2001-05-11
GB0111597A GB2377633A (en) 2001-05-11 2001-05-11 Pharmaceutical compositions comprising the cannabinoids THC and CBD
GB0121715A GB2381194A (en) 2001-09-07 2001-09-07 Pharmaceutical formulations
GB0121715.7 2001-09-07
US09/951,022 US7025992B2 (en) 2001-02-14 2001-09-12 Pharmaceutical formulations
US09/951,022 2001-09-12
CA002438097A CA2438097C (fr) 2001-02-14 2002-02-14 Preparations pharmaceutiques cannabinoides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002438097A Division CA2438097C (fr) 2001-02-14 2002-02-14 Preparations pharmaceutiques cannabinoides

Publications (2)

Publication Number Publication Date
CA2533400A1 CA2533400A1 (fr) 2002-08-22
CA2533400C true CA2533400C (fr) 2017-01-03

Family

ID=36178059

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2533400A Expired - Lifetime CA2533400C (fr) 2001-02-14 2002-02-14 Preparations pharmaceutiques cannabinoides

Country Status (1)

Country Link
CA (1) CA2533400C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020044121A1 (fr) * 2018-08-27 2020-03-05 Emerald Health Therapeutics Canada Inc. Formulations orales de phénylalanine et de cannabinoïdes

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180303791A1 (en) * 2014-11-26 2018-10-25 One World Cannabis Ltd Synergistic use of cannabis for treating multiple myeloma
AU2017290107A1 (en) 2016-06-29 2019-01-17 CannScience Innovations Inc. Decarboxylated cannabis resins, uses thereof and methods of making same
WO2020061687A1 (fr) * 2018-09-28 2020-04-02 Visceral Therapeutics Inc. Compositions pharmaceutiquement actives à base de cannabis et procédés d'utilisation pour traiter des affections gastro-intestinales

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020044121A1 (fr) * 2018-08-27 2020-03-05 Emerald Health Therapeutics Canada Inc. Formulations orales de phénylalanine et de cannabinoïdes

Also Published As

Publication number Publication date
CA2533400A1 (fr) 2002-08-22

Similar Documents

Publication Publication Date Title
AU2002231970B2 (en) Mucoadhesive pharmaceutical formulations
US10004684B2 (en) Pharmaceutical formulations
US7025992B2 (en) Pharmaceutical formulations
AU2002231970A1 (en) Mucoadhesive pharmaceutical formulations
US20190322427A1 (en) Pharmaceutical formulation
US6730330B2 (en) Pharmaceutical formulations
CA2454644C (fr) Formulations de cannabinoides liquides administrees par les muqueuses
US10807777B2 (en) Pharmaceutical formulation
US20180042842A1 (en) Pharmaceutical formulations
ZA200501228B (en) Cannabinoid liquid formulations of mucosal administration
GB2381194A (en) Pharmaceutical formulations
CN1886117B (zh) 药物制剂
GB2380129A (en) Self-emulsifying pharmaceutical compositions
CA2533400C (fr) Preparations pharmaceutiques cannabinoides
TWI222882B (en) Pharmaceutical formulations
PL216740B1 (pl) Preparat w postaci płynnego sprayu

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20220214